Announce Date | 02/19/2025 |
EPS Normalized Actual | $0.89 (Miss by $-0.38) |
EPS GAAP Actual | $0.89 (Miss by $-0.38) |
Revenue Actual | $1.963B |
Revenue Surprise | Beat by $1963M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.01 |
EPS GAAP Estimate | $1.01 |
Revenue Estimate | $2.753298819B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2.29 | 20.25 | 1.89134 | 2.54186 | 1 |
Dec 2028 | 1.73 | 26.81 | 1.73 | 1.73 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.88 | -0.1 | 1.963B | 35% | 253M |
FQ4 2024 (Dec 2024) | 1.03 | -0.76 | 1.75B | 100% | -1451M |
FQ3 2024 (Sep 2024) | 0.53 | -1.01141 | 1.491B | 100% | -1114.5M |
FQ1 2024 (Mar 2024) | 0.37 | -0.61 | 1.276B | 100% | -1898.89M |
FQ2 2024 (Jun 2024) | 0.74 | -0.60259 | 2.552B | 100% | 236M |
FQ1 2016 (Mar 2016) | 0.0634 | 0.0634 | 0.98B | 100% | 980M |
FQ3 2016 (Sep 2016) | 0.0103 | 0.0103 | 1.0625B | 100% | 1062.5M |
FQ1 2017 (Mar 2017) | -0.22 | -0.22 | 1.0565B | 7.24% | 1056.5M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
1.01
Consensus Revenue Estimates
2.753298819B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.1573 | -- | 1.1573 | 1.1573 | 1 |
FQ2 2027 (Jun 2027) | 1.1025 | -- | 1.1025 | 1.1025 | 1 |
FQ1 2027 (Mar 2027) | 1.115 | -- | 1.115 | 1.115 | 1 |
FQ4 2026 (Dec 2026) | 1.09 | -- | 1.09 | 1.09 | 1 |
FQ3 2026 (Sep 2026) | 1.26 | -- | 1.26 | 1.26 | 1 |
FQ2 2026 (Jun 2026) | 1.26 | -- | 1.26 | 1.26 | 1 |
FQ1 2026 (Mar 2026) | 1.08 | 18.52 | 1.08 | 1.08 | 1 |
FQ4 2025 (Dec 2025) | 1.02 | -0.98 | 1.02 | 1.02 | 1 |
FQ3 2025 (Sep 2025) | 1.07 | 50.47 | 1.07 | 1.07 | 1 |
FQ2 2025 (Jun 2025) | 1.01 | 26.73 | 1.01 | 1.01 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.21B | -- | 2.21B | 2.21B | 1 |
FQ2 2027 (Jun 2027) | 2.13B | -- | 2.13B | 2.13B | 1 |
FQ1 2027 (Mar 2027) | 2.16B | -- | 2.16B | 2.16B | 1 |
FQ4 2026 (Dec 2026) | 1.77B | -- | 1.77B | 1.77B | 1 |
FQ3 2026 (Sep 2026) | 2.1B | -- | 2.1B | 2.1B | 1 |
FQ2 2026 (Jun 2026) | 1.7B | -- | 1.7B | 1.7B | 1 |
FQ1 2026 (Mar 2026) | 1.92B | -2.14 | 1.92B | 1.92B | 1 |
FQ4 2025 (Dec 2025) | 2.86B | 38.81 | 2.86B | 2.86B | 1 |
FQ3 2025 (Sep 2025) | 2.81B | 46.86 | 2.81B | 2.81B | 1 |
FQ2 2025 (Jun 2025) | 2.75B | 7.31 | 2.75B | 2.75B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.98 | 0.88 | -0.1 | -11.36% |
FQ4 2024 (Dec 2024) | 1.79 | 1.03 | -0.76 | -73.79% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.53 | -1.01141 | -190.83% |
FQ1 2024 (Mar 2024) | 0.98 | 0.37 | -0.61 | -164.86% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.74 | -0.60259 | -81.43% |
FQ1 2016 (Mar 2016) | 0.0634 | 0.0634 | 100% | |
FQ3 2016 (Sep 2016) | 0.0103 | 0.0103 | 100% | |
FQ1 2017 (Mar 2017) | -0.22 | -0.22 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.71B | $1.96B | $253M | 12.89% |
FQ4 2024 (Dec 2024) | $3.2B | $1.75B | $-1451M | -82.91% |
FQ3 2024 (Sep 2024) | $2.61B | $1.49B | $-1114.5M | -74.75% |
FQ1 2024 (Mar 2024) | $3.17B | $1.28B | $-1898.89M | -148.82% |
FQ2 2024 (Jun 2024) | $2.32B | $2.55B | $236M | 9.25% |
FQ1 2016 (Mar 2016) | $0B | $0.98B | $980M | 100% |
FQ3 2016 (Sep 2016) | $0B | $1.06B | $1062.5M | 100% |
FQ1 2017 (Mar 2017) | $0B | $1.06B | $1056.5M | 100% |